| Cash Flow | 2025-09-30 |
|---|---|
| Net income (loss) | 1,319 |
| Provision for credit losses | 363 |
| Depreciation, amortization, and accretion, net | 18 |
| Increase in cash surrender value of corporate-owned life insurance | 90 |
| Stock-based compensation expense | 99 |
| Deferred income taxes (benefit) | 15 |
| Proceeds from sales of loans held for sale | 6,756 |
| Originations of loans held for sale, net of repayments | 6,935 |
| Net losses (gains) on sales of loans held for sale | 93 |
| Net losses (gains) on leased equipment | 0 |
| Net securities and other investments losses (gains) | -6 |
| Net losses (gains) on sales of fixed assets | 0 |
| Trading account assets | -311 |
| Accrued income and other assets | 77 |
| Accrued expense and other liabilities | -694 |
| Other operating activities, net | -522 |
| Net cash provided by (used in) operating activities | 1,490 |
| Net decrease (increase) in short-term investments, excluding acquisitions | -4,170 |
| Purchases of securities available for sale | 6,517 |
| Proceeds from sales of securities available for sale | 5 |
| Proceeds from prepayments and maturities of securities available for sale | 4,976 |
| Proceeds from prepayments and maturities of held-to-maturity securities | 759 |
| Purchases of held-to-maturity securities | 868 |
| Net decrease (increase) in other investments | 120 |
| Net decrease (increase) in loans, excluding acquisitions, sales and transfers | 1,950 |
| Proceeds from sales of portfolio loans | 122 |
| Proceeds from corporate-owned life insurance | 56 |
| Purchases of premises, equipment, and software | 62 |
| Proceeds from sales of premises and equipment | 3 |
| Net cash provided by (used in) investing activities | 814 |
| Net increase (decrease) in deposits | 1,005 |
| Net increase (decrease) in short-term borrowings | -795 |
| Net proceeds from issuance of long-term debt | 1,484 |
| Payments on long-term debt | 2,981 |
| Employee equity compensation program common share repurchases | 35 |
| Net proceeds from reissuance of common shares | 5 |
| Net proceeds from scotiabank investment | 0 |
| Cash dividends paid | 792 |
| Net cash provided by (used in) financing activities | -2,109 |
| Net increase (decrease) in cash and due from banks | 195 |
| Cash and cash equivalents at beginning of period | 1,743 |
| Cash and cash equivalents at end of period | 1,938 |
KEYCORP NEW (KEY-PI)
KEYCORP NEW (KEY-PI)